This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Eurofins Lifecodexx Gmbh. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Steffi Werler: Innovator in Fetal Chromosomal Detection
Introduction
Steffi Werler is a prominent inventor based in Constance, Germany. She has made significant contributions to the field of prenatal diagnostics, particularly in the detection of fetal chromosomal aneuploidies. Her innovative methods have the potential to improve outcomes for pregnant women and their unborn children.
Latest Patents
Steffi Werler holds a patent for her groundbreaking work titled "Detection of fetal chromosomal aneuploidies using DNA regions that are differentially methylated between the fetus and the pregnant female." This patent outlines methods for detecting chromosomal aneuploidies in a fetus by analyzing DNA samples that contain both fetal and maternal DNA. The methods utilize differential methylation patterns to provide diagnostic, prognostic, and predictive insights, particularly for conditions such as trisomy.
Career Highlights
Werler is associated with Eurofins Lifecodexx GmbH, where she continues to advance her research and development efforts. Her work has garnered attention for its potential to revolutionize prenatal testing and improve the health of mothers and their babies.
Collaborations
Steffi collaborates with notable colleagues, including Wera Hofmann and Matthias Sachse, who contribute to her research initiatives and help drive innovation in the field.
Conclusion
Steffi Werler's contributions to prenatal diagnostics exemplify the impact of innovative thinking in healthcare. Her patented methods for detecting fetal chromosomal aneuploidies represent a significant advancement in medical technology, promising better outcomes for expectant families.